Preserving muscle mass with antiobesity medications, investigating the relationship between sensor-detected hypoglycemia and patient-reported hypoglycemia, and more!
Welcome to episode no. 25 (October 2024) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the October 2024 issue of Diabetes Care and beyond.
0:40 Alice and Mike ring in Fall with a special offer from the ADA for new and renewing members: a 15% discount on a 1- or 2-year membership. Go to professional.diabetes.org/membership, create your account, fill out the application, and use the discount code ‘FALL24’ at checkout. Act fast because this offer expires November 30, 2024!
3:55 Alice interviews Dr. Bu B. Yeap, an endocrinologist and professor in the medical school at University of Western Australia in Perth, Australia. He is a corresponding author of “Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?” a narrative review which highlights the degree to which new antiobesity medications cause loss of lean mass, and the importance of resistance exercise in preserving muscle. The review is available at doi.org/10.2337/dci23-0100.
16:45 Mike welcomes Dr. Patrick Divilly, lead author of “Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study.” This study is available at doi.org/10.2337/dc23-2332.
31:55 In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the October 2024 issue of Diabetes Care. Studies highlighted in this segment include:
Ye et al. Large-Scale Proteomics Improve Prediction of Chronic Kidney Disease in People With Diabetes. doi.org/10.2337/dc24-0290
Borel et al. Closed-Loop Insulin Therapy for People With Type 2 Diabetes Treated With an Insulin Pump: A 12-Week Multicenter, Open-Label Randomized, Controlled, Crossover Trial. doi.org/10.2337/dc24-0623
Atta et al. Associations of High BMI and Excessive Gestational Weight Gain With Pregnancy Outcomes in Women With Type 1 Diabetes: A Systematic Review and Meta-analysis doi.org/10.2337/dc24-0725
Yeh Lee et al. Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin doi.org/10.2337/dc24-0626
Huang et al. Comprehensive Multiple Risk Factor Control in Type 2 Diabetes to Mitigate Heart Failure Risk: Insights From a Prospective Cohort Study doi.org/10.2337/dc24-0864
Podden och tillhörande omslagsbild på den här sidan tillhör American Diabetes Association. Innehållet i podden är skapat av American Diabetes Association och inte av, eller tillsammans med, Poddtoppen.